TVTX logo

Travere Therapeutics, Inc. (TVTX) Return On Assets

Annual ROA:

-46.37%+5.13%(+9.96%)
December 31, 2024

Summary

  • As of today, TVTX annual return on assets is -46.37%, with the most recent change of +5.13% (+9.96%) on December 31, 2024.
  • During the last 3 years, TVTX annual ROA has fallen by -20.35% (-78.21%).
  • TVTX annual ROA is now -234.06% below its all-time high of 34.59%, reached on December 31, 2015.

Performance

TVTX ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXprofitability metrics

Quarterly ROA:

-30.69%+8.78%(+22.24%)
June 30, 2025

Summary

  • As of today, TVTX quarterly return on assets is -30.69%, with the most recent change of +8.78% (+22.24%) on June 30, 2025.
  • Over the past year, TVTX quarterly ROA has increased by +22.97% (+42.81%).
  • TVTX quarterly ROA is now -204.74% below its all-time high of 29.30%, reached on December 31, 2015.

Performance

TVTX Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherTVTXprofitability metrics

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

TVTX ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+10.0%+42.8%
3Y3 Years-78.2%-4.1%
5Y5 Years-113.2%-108.1%

TVTX ROA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-78.2%+10.0%at high+42.8%
5Y5-Year-113.2%+10.0%-148.7%+42.8%
All-TimeAll-Time-234.1%+98.2%-204.7%+99.5%

TVTX ROA History

DateAnnualQuarterly
Jun 2025
-
-30.69%(+22.2%)
Mar 2025
-
-39.47%(+23.6%)
Dec 2024
-46.37%(+10.0%)
-51.68%(+1.1%)
Sep 2024
-
-52.23%(+2.7%)
Jun 2024
-
-53.66%(-2.9%)
Mar 2024
-
-52.14%(-11.2%)
Dec 2023
-51.50%(-12.6%)
-46.89%(+0.8%)
Sep 2023
-
-47.28%(-0.0%)
Jun 2023
-
-47.26%(-8.2%)
Mar 2023
-
-43.68%(-5.7%)
Dec 2022
-45.74%(-75.8%)
-41.33%(-15.3%)
Sep 2022
-
-35.85%(-21.6%)
Jun 2022
-
-29.47%(-13.4%)
Mar 2022
-
-25.98%(-5.9%)
Dec 2021
-26.02%(+6.9%)
-24.54%(+29.6%)
Sep 2021
-
-34.88%(-2.7%)
Jun 2021
-
-33.97%(-0.5%)
Mar 2021
-
-33.80%(-25.9%)
Dec 2020
-27.95%(-28.5%)
-26.84%(-117.5%)
Sep 2020
-
-12.34%(+16.3%)
Jun 2020
-
-14.75%(+12.4%)
Mar 2020
-
-16.84%(+24.7%)
Dec 2019
-21.75%(-35.4%)
-22.35%(-22.5%)
Sep 2019
-
-18.25%(+15.9%)
Jun 2019
-
-21.70%(-8.0%)
Mar 2019
-
-20.09%(-16.9%)
Dec 2018
-16.06%(-48.6%)
-17.19%(+15.7%)
Sep 2018
-
-20.40%(-37.0%)
Jun 2018
-
-14.89%(-14.5%)
Mar 2018
-
-13.01%(-15.1%)
Dec 2017
-10.81%
-11.30%(-17.6%)
Sep 2017
-
-9.61%(+27.3%)
Jun 2017
-
-13.21%(+0.2%)
DateAnnualQuarterly
Mar 2017
-
-13.24%(-46.6%)
Dec 2016
-8.63%(-124.9%)
-9.03%(-12.3%)
Sep 2016
-
-8.04%(-139.7%)
Jun 2016
-
20.26%(+8.2%)
Mar 2016
-
18.72%(-36.1%)
Dec 2015
34.59%(+124.3%)
29.30%(+5.6%)
Sep 2015
-
27.74%(+305.8%)
Jun 2015
-
-13.48%(-5516.7%)
Mar 2015
-
-0.24%(+99.8%)
Dec 2014
-142.26%(+53.0%)
-100.39%(+7.1%)
Sep 2014
-
-108.05%(+26.0%)
Jun 2014
-
-145.97%(+57.8%)
Mar 2014
-
-346.24%(-7.2%)
Dec 2013
-302.53%(+88.1%)
-322.98%(+60.3%)
Sep 2013
-
-812.90%(+59.4%)
Jun 2013
-
-2001.97%(+16.1%)
Mar 2013
-
-2385.44%(+62.2%)
Dec 2012
-2533.62%(-373.7%)
-6303.24%(-1644.2%)
Nov 2011
-
-361.39%(+10.1%)
Aug 2011
-
-401.91%(+12.8%)
May 2011
-
-460.65%(+10.7%)
Feb 2011
-534.88%(+10.2%)
-515.70%(+8.4%)
Nov 2010
-
-563.04%(+2.5%)
Aug 2010
-
-577.59%(-0.5%)
May 2010
-
-574.79%(+2.8%)
Feb 2010
-595.74%(+21.9%)
-591.10%(+1.3%)
Nov 2009
-
-598.74%(-10.1%)
Aug 2009
-
-543.57%(-17.4%)
May 2009
-
-463.11%(-23.3%)
Feb 2009
-762.50%
-375.51%(-71.5%)
Nov 2008
-
-218.92%(-68.4%)
Aug 2008
-
-130.00%(-91.2%)
May 2008
-
-68.00%

FAQ

  • What is Travere Therapeutics, Inc. annual return on assets?
  • What is the all-time high annual ROA for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. annual ROA year-on-year change?
  • What is Travere Therapeutics, Inc. quarterly return on assets?
  • What is the all-time high quarterly ROA for Travere Therapeutics, Inc.?
  • What is Travere Therapeutics, Inc. quarterly ROA year-on-year change?

What is Travere Therapeutics, Inc. annual return on assets?

The current annual ROA of TVTX is -46.37%

What is the all-time high annual ROA for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high annual return on assets is 34.59%

What is Travere Therapeutics, Inc. annual ROA year-on-year change?

Over the past year, TVTX annual return on assets has changed by +5.13% (+9.96%)

What is Travere Therapeutics, Inc. quarterly return on assets?

The current quarterly ROA of TVTX is -30.69%

What is the all-time high quarterly ROA for Travere Therapeutics, Inc.?

Travere Therapeutics, Inc. all-time high quarterly return on assets is 29.30%

What is Travere Therapeutics, Inc. quarterly ROA year-on-year change?

Over the past year, TVTX quarterly return on assets has changed by +22.97% (+42.81%)
On this page